🇺🇸 Diclofenac diethylamine in United States

13,723 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 23 April 2025 – 23 April 2026
• Total reports: 13,723

Most-reported reactions

1. Off Label Use — 1,721 reports (12.54%)
2. Pain — 1,445 reports (10.53%)
3. Joint Swelling — 1,385 reports (10.09%)
4. Drug Ineffective — 1,349 reports (9.83%)
5. Fatigue — 1,334 reports (9.72%)
6. Glossodynia — 1,327 reports (9.67%)
7. Pemphigus — 1,324 reports (9.65%)
8. Rheumatoid Arthritis — 1,294 reports (9.43%)
9. Arthralgia — 1,280 reports (9.33%)
10. Systemic Lupus Erythematosus — 1,264 reports (9.21%)

Source database →

Frequently asked questions

Is Diclofenac diethylamine approved in United States?

Diclofenac diethylamine does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Diclofenac diethylamine in United States?

Taisho Pharmaceutical Co., Ltd. is the originator. The local marketing authorisation holder may differ — check the official source linked above.